KPMG, McKinsey, Deloitte and PwC have a controlling influence on NHS Monitor and are also major beneficiaries

Who is looking after the interests of the ordinary citizen and tax payer as the privatisation of the NHS gathers pace?

Take a look (see below) at the Executive team of Monitor, the NHS’s economic regulator. You will see KPMG, McKinsey, Deloitte and PwC have pretty much got the board sown up. I don’t see anyone there who will look after the interests of the taxpayer/patient/citizen.  What I do see is yet another example of the legalised corruption called the ‘revolving door’ where advisers and decision makers can move from private companies into government and then back again with resulting huge conflicts of interest.  All of these companies stand to gain financially from the huge and unprecedented sums of money that are being diverted from the NHS into the private sector and have already been caught lobbying for the interests of private health care companies[1]

According to the Yorkshire Post [2] “NHS regulator Monitor spent 40 per cent of its budget on millions of pounds of advice from five big firms of private consultants in the last year”.

The contracts totalling £7.8m include an “interim fee” of £1m for work by turnaround experts from Ernst & Young at the scandal-hit Mid Staffordshire NHS trust.

Figures for 2012-13 show Monitor also paid PwC £3m, McKinsey £1.9m, KPMG £1.1m and Deloitte £800,000 from its £19.5m budget.

Looks like Monitor is a conduit for transferring tax payers cash from the NHS to the big accountancy and management consultancy firms.


Monitor – Executive team:

Dr David Bennett (Chief Executive) David has worked for some years in and around the public sector. Before joining Monitor he was the non-political Chief Policy Advisor to Prime Minister Tony Blair and Head of the Policy Directorate and the Strategy Unit in 10 Downing Street. He has also worked as an independent advisor to various NHS bodies. Before this, David was a senior partner at McKinsey & Co.

Stephen Hay (Managing Director of Provider Regulation) Stephen worked at Monitor on an interim basis, on secondment from KPMG, from December 2003 and was appointed on a permanent basis in October 2004.  A qualified Chartered Accountant, previously Stephen worked with KPMG, latterly as a Director within the Transaction Services Department. He has advised the boards of corporate and private equity houses and his portfolio of financial experience is wide-ranging and includes mergers and acquisitions, due diligence, IPOs, and risk assessment.

Adrian Masters (Managing Director of Sector Development) Adrian was previously Director of the Health Team in the Prime Minister’s Delivery Unit. Prior to that, Adrian’s career included spells with McKinsey, IBM and Price Waterhouse. He qualified as an accountant, and has an MBA from Stanford University.

Miranda Carter (Executive Director of Assessment) A qualified chartered accountant, Miranda started her career at Deloitte as an auditor in 1991, working in the UK and Hong Kong. In 1997 Miranda joined Price Waterhouse Coopers, and spent four years in the Transaction Services Department in London, focusing on due diligence assignments. She has advised the boards of corporate and private equity houses and her portfolio of financial experience is wide-ranging and includes mergers and acquisitions, due diligence and initial public offerings (IPOs).

Catherine Davies (Executive Director of Co-operation and Competition) Catherine is a competition law specialist with experience in all aspects of EU and UK competition law, having advised on mergers and acquisitions, joint ventures, distribution arrangements and market investigations across a wide range of sectors, including consumer goods, energy, media and healthcare. Catherine also has experience of public procurement law and judicial review. Before joining the CCP in February 2009 as Legal Director, she worked at the Competition Commission and a large City law firm.

Kate Moore (Executive Director of Legal Services) Kate has extensive experience of regulatory, litigation and public law gained through her previous roles at city law firms, as Director of Legal at the Investors Compensation Scheme and as a principal consultant withKPMG.

Sue Meeson (Executive Director of Strategic Communications) Sue was previously Director of Communications for the Legal Services Commission, which runs the legal aid system, and held a variety of corporate communication roles with Unilever. Her experience covers all aspects of internal and external communications, including media relations, change communications, public affairs and stakeholder engagement.

Source: (Accessed 14th Jan 2013)

You can also check out the non executive board – you will find the pretty much the same companies with a majority stake:


[1] Monitor lobbying for private health care companies:
NHS is being outsourced to private health care companies that will be exempt from Freedom of Information requests. Due to commercial confidentiality, these companies will enjoy secret contracts with none of the  transparency expected in the NHS and the Public Sector. If this was not worrying enough, it also appears that Monitor, the NHS’s economic regulator, has been caught arguing that the private health care companies providing NHS services should be exempt from paying corporation tax.  It is clearly ridiculous for companies to lobby to provide NHS services for profit and then to claim it is unfair to pay tax on their profits but that is exactly what they are after. In fact, when exposed,  Monitor back tracked on this lobbying and went rather quiet but don’t expect them to give up.

[2] Exclusive: NHS regulator spends 40% of budget on consultants Yorkshire Post 3rd May 2013

Private NHS providers in line for corporation tax exemption: Labour calls on government not to ‘let the tax avoiders into the NHS’ after revelations in review by Monitor (Randeep Ramesh, social affairs editor The Guardian, Sunday 13 January 2013)

Private health care firms performing NHS services may not have to pay corporation tax on their profits under draft proposals being considered as part of a government-commissioned review into NHS competition. (Daily Telegraph 13th Jan 2013)


Head of Monitor Has Ties with Private Healthcare Lobby Group Who See Tax, Pensions and NHS Brand as Barrier in ‘Fair Playing Field’ Review. (Social Investigations, 16th Jan 2013)

More Health / NHS

The Shadow Government – Through a network of unbalanced, almost-invisible committees, the government gets what it wants. (By George Monbiot, published in the Guardian 13th March 2012)


UPDATE (Jan 2014): Monitor Spend Close to Half Million on 23 New Recruits Using Two Companies Financially Linked to Lords (Monitor was recently exposed as having spent 40% of their overall budget on private consultants, which included £1.9million to David Bennett’s former firm Mckinsey.)

Share this post:

2 thoughts on “KPMG, McKinsey, Deloitte and PwC have a controlling influence on NHS Monitor and are also major beneficiaries”

  1. Whilst working at a small electronics company in cirencester we had need of about 15metres of special very expensive cable for a customer. Our purchaser decided to buy a cut length at a few pence less than a reel of 50metres – why? because the 35metres remaining in stores would cost the company money as stock.
    The same acountant lunacy in the NHS will see 3.25 boxes of gloves purchased because that’s all they need till the end of the financial year. Then they will pat themselves on the back for saving £50.
    Accountants; some of the first people up against the wall come the revolution! :o)

  2. The scandal of Mid staffs is that the man who was in charge got promoted to the highest position in the NHS then decided he would retire on his terms when he was ready when he should have been sacked. Since he went the hospital had pulled itself up and is now one of the best in the country, but will be closed because of journalists wanting cheap quotes always denigrating it, and the general underfunding of the NHS which the government has denounced its accountability for, is going to lead to more hospitals having to suffer the same lies that will destroy a perfectly good hospital.

Comments are closed.